|
1.
|
Lewis MM, Galley S, Johnson S, Stevenson J, Huang X, McKeown MJ. The role of the cerebellum in the pathophysiology of Parkinson's disease. Can J Neurol Sci. 2013 May; 40(3):299-306.
|
|
|
|
|
2.
|
Lewis MM, Du G, Kidacki M, Patel N, Shaffer ML, Mailman RB, Huang X. Higher iron in the red nucleus marks Parkinson's dyskinesia. Neurobiol Aging. 2013 May; 34(5):1497-503.
|
|
|
|
|
3.
|
Du G, Lewis MM, Sen S, Wang J, Shaffer ML, Styner M, Yang QX, Huang X. Imaging nigral pathology and clinical progression in Parkinson's disease. Mov Disord. 2012 Nov; 27(13):1636-43.
|
|
|
|
|
4.
|
Du G, Lewis MM, Shaffer ML, Chen H, Yang QX, Mailman RB, Huang X. Serum cholesterol and nigrostriatal R2* values in Parkinson's disease. PLoS One. 2012; 7(4):e35397.
|
|
|
|
|
5.
|
Huang X, Mahoney JM, Lewis MM. Both coordination and symmetry of arm swing are reduced in Parkinson's disease. Gait Posture. 2012 Mar; 35(3):373-7.
|
|
|
|
|
6.
|
Du G, Lewis MM, Styner M, Shaffer ML, Sen S, Yang QX, Huang X. Combined R2* and diffusion tensor imaging changes in the substantia nigra in Parkinson's disease. Mov Disord. 2011 Aug 1; 26(9):1627-32.
|
|
|
|
|
7.
|
Lewis MM, Du G, Sen S, Kawaguchi A, Truong Y, Lee S, Mailman RB, Huang X. Differential involvement of striato- and cerebello-thalamo-cortical pathways in tremor- and akinetic/rigid-predominant Parkinson's disease. Neuroscience. 2011 Mar 17; 177:230-9.
|
|
|
|
|
8.
|
Lee, S., Shen, J., Truong, Y., Lewism M.M., and Huang X. Journal of the American Statistical Association. Independent component analysis involving autocorrelated sources with an application to functional magnetic resonance imaging. 2011.
|
|
|
|
|
9.
|
Sen S, Kawaguchi A, Truong Y, Lewis MM, Huang X. Dynamic changes in cerebello-thalamo-cortical motor circuitry during progression of Parkinson's disease. Neuroscience. 2010 Mar 17; 166(2):712-9.
|
|
|
|
|
10.
|
Lewis MM, Smith AB, Styner M, Gu H, Poole R, Zhu H, Li Y, Barbero X, Gouttard S, McKeown MJ, Mailman RB, Huang X. Asymmetrical lateral ventricular enlargement in Parkinson's disease. Eur J Neurol. 2009 Apr; 16(4):475-81.
|
|
|
|
|
11.
|
McKeown MJ, Uthama A, Abugharbieh R, Palmer S, Lewis M, Huang X. Shape (but not volume) changes in the thalami in Parkinson disease. BMC Neurol. 2008; 8:8.
|
|
|
|
|
12.
|
Huang X, Lee YZ, McKeown M, Gerig G, Gu H, Lin W, Lewis MM, Ford S, Tröster AI, Weinberger DR, Styner M. Asymmetrical ventricular enlargement in Parkinson's disease. Mov Disord. 2007 Aug 15; 22(11):1657-60.
|
|
|
|
|
13.
|
McKeown MJ, Li J, Huang X, Lewis MM, Rhee S, Young Truong KN, Wang ZJ. Local linear discriminant analysis (LLDA) for group and region of interest (ROI)-based fMRI analysis. Neuroimage. 2007 Sep 1; 37(3):855-65.
|
|
|
|
|
14.
|
Lewis MM, Slagle CG, Smith AB, Truong Y, Bai P, McKeown MJ, Mailman RB, Belger A, Huang X. Task specific influences of Parkinson's disease on the striato-thalamo-cortical and cerebello-thalamo-cortical motor circuitries. Neuroscience. 2007 Jun 15; 147(1):224-35.
|
|
|
|
|
15.
|
Lewis MM, Huang X, Nichols DE, Mailman RB. D1 and functionally selective dopamine agonists as neuroprotective agents in Parkinson's disease. CNS Neurol Disord Drug Targets. 2006 Jun; 5(3):345-53.
|
|
|
|
|
16.
|
Grubbs RA, Lewis MM, Owens-Vance C, Gay EA, Jassen AK, Mailman RB, Nichols DE. 8,9-dihydroxy-1,2,3,11b-tetrahydrochromeno[4,3,2,-de]isoquinoline (dinoxyline), a high affinity and potent agonist at all dopamine receptor isoforms. Bioorg Med Chem. 2004 Mar 15; 12(6):1403-12.
|
|
|
|
|
17.
|
Qandil AM, Lewis MM, Jassen A, Leonard SK, Mailman RB, Nichols DE. Synthesis and pharmacological evaluation of substituted naphth[1,2,3-de]isoquinolines (dinapsoline analogues) as D1 and D2 dopamine receptor ligands. Bioorg Med Chem. 2003 Apr 3; 11(7):1451-64.
|
|
|
|
|
18.
|
Mottola DM, Kilts JD, Lewis MM, Connery HS, Walker QD, Jones SR, Booth RG, Hyslop DK, Piercey M, Wightman RM, Lawler CP, Nichols DE, Mailman RB. Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D2 receptors linked to adenylate cyclase. J Pharmacol Exp Ther. 2002 Jun; 301(3):1166-78.
|
|
|
|
|
19.
|
Kilts JD, Connery HS, Arrington EG, Lewis MM, Lawler CP, Oxford GS, O'Malley KL, Todd RD, Blake BL, Nichols DE, Mailman RB. Functional selectivity of dopamine receptor agonists. II. Actions of dihydrexidine in D2L receptor-transfected MN9D cells and pituitary lactotrophs. J Pharmacol Exp Ther. 2002 Jun; 301(3):1179-89.
|
|
|
|
|
20.
|
Huang, X., Lawler, C.P., Nichols, D.E., Lewis, M.M., and Mailman, R.B. International Review of Neurobiology. D1 Dopamine Receptors. 2001; 48:66-138.
|
|
|
|
|
21.
|
Doll, M.K., Nichols, D.E., Kilts, J.D., Prioleau, C., Lawler, C.P., Lewis, M.M., and Mailman, R.B. J Med Chem. Synthesis and dopaminergic properties of benzo-fused analogues of quinpirole and quinelorane. 1999; 42:935-940.
|
|
|
|
|
22.
|
Lawler, C.P., Prioleau, C., Lewis, M.M., Mak, C., Jiang, D., Schetz, J.A., Gonzalez, A.M., Sibley, D.R., and Mailman, R.B. Neuropsychopharmacology. Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes. 1999; 20:612-627.
|
|
|
|
|
23.
|
Mailman, RB, Nichols, DE, Lewis, MM, Blake, B, and Lawler, CP. Dopamine Receptor Subtypes: From Basic Science to Clinical Application, P Jenner and R Demirdemar (eds). Functional effects of novel dopamine ligands: Dihydrexidine and Parkinson's disease as a first step. 1998; 64-83.
|
|
|
|
|
24.
|
Lewis, MM, Watts, VJ, Lawler, CP, Nichols, DE, and Mailman, RB. J Pharmacol Exp Ther. Desensitization of the D1A dopamine receptor: Efficacy in causing desensitization dissociates from both receptor occupancy and functional potency. 1998; 286:345-353.
|
|
|
|
|
25.
|
Monte, AP, Marona-Lewicka, D, Lewis, MM, Mailman, RB, Wainscott, DB, Nelson, DL, and Nichols, DE. J Med Chem. Substituted naphthofurans as hallucinogenic phenethylamine-ergoline hybrid molecules with unexpected muscarinic antagonist activity. 1998; 41:2134-2145.
|
|
|
|
|
26.
|
Mailman, RB, Mayleben, M, and Lawler, CP. Toxicology of metals, L Magos, T Suzuki, and L Chang, (eds). Effects of toxic metals on neurotransmitters. 1996.
|
|
|
|
|
27.
|
Davis, SF, Nation, JR, and Mayleben, MA. Toxicology Letters. The effects of chronic lead exposure on reactivity to frustrative nonreward in rats. 1993; 66:237-246.
|
|
|
|
|
28.
|
Watts, VJ, Lawler, CP, Knoerzer, T, Mayleben, MA, Neve, KA, Nichols, DE, and Mailman, RB. Eur J Pharmacol. Hexahydrobenzo[a]phenanthridines: Ligands with high affinity and selectivity for D3 dopamine receptors. 1993; 239:271-273.
|
|
|
|
|
29.
|
Lawler, CP, Gilmore, JH, Mooney, DH, Mayleben, MA, Atashi, JA, Mileson, BE, Wyrick, SD, and Mailman, RB. J Neurosci Meth. A rapid and efficient method for the radiosynthesis and purification of [125I]-SCH23982. 1993; 49:141-153.
|
|
|
|
|
30.
|
Davis, SF, Bailey, SA, Mayleben, MA, Freeman, BL, and Page, C. BUlletin of the Psychonomic Society. The effects of exposure to a protein- and tryptophan-deficient diet upon taste-aversion learning. 1991; 29:128-130.
|
|
|
|
|
31.
|
Miller, HR and Mayleben, MA. Psi Chi Newsletter. Going to the national Psi Chi convention. 1991; 17:6.
|
|
|
|
|
32.
|
McGregor, L, Mayleben, MA, Buzzanga, VL, Davis, SF, and Becker, AH. College Student Journal. Selected personality characteristics of first-generation college students. 1991; 25(2):231-234.
|
|
|
|
|
33.
|
Davis, SF, Best, MR, Grover, CA, Bailey, SA, Freeman, BL, and Mayleben, MA. Animal Learning and Behavior. The effects of taste extinction on ingestional potentiation in weanling rats. 1990; 18:444-452.
|
|
|
|